Capital Advisors, Ltd. LLC Pfizer Inc Transaction History

Capital Advisors, Ltd. LLC

$793 Million
Q4 2024

A detailed history of Capital Advisors, Ltd. LLC transactions in Pfizer Inc stock. As of the latest transaction made, Capital Advisors, Ltd. LLC holds 14,182 shares of PFE stock, worth $367,171. This represents 0.05% of its overall portfolio holdings.

Number of Shares

14,182

Previous 14,365 1.27%

Holding current value

$367,171

Previous $416,000 9.62%

% of portfolio

0.05%

Previous 0.05%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	SELL	$24.8 - $30.19 $4,538 - $5,524	-183 Reduced 1.27%	14,182 $376,000
Q3 2024 Oct 24, 2024	BUY	$27.7 - $31.39 $55 - $62	2 Added 0.01%	14,365 $416,000
Q2 2024 Jul 25, 2024	SELL	$25.26 - $29.6 $10,912 - $12,787	-432 Reduced 2.92%	14,363 $402,000
Q1 2024 Apr 18, 2024	SELL	$25.89 - $29.73 $1,061 - $1,218	-41 Reduced 0.28%	14,795 $411,000
Q4 2023 Feb 02, 2024	BUY	$26.13 - $33.94 $25,555 - $33,193	978 Added 7.06%	14,836 $427,000
Q3 2023 Oct 27, 2023	SELL	$32.09 - $37.51 $14,857 - $17,367	-463 Reduced 3.23%	13,858 $460,000
Q2 2023 Jul 26, 2023	BUY	$36.12 - $41.79 $112,405 - $130,050	3,112 Added 27.76%	14,321 $525,000
Q1 2023 May 03, 2023	BUY	$39.39 - $51.28 $28,400 - $36,972	721 Added 6.87%	11,209 $457,000
Q4 2022 Feb 07, 2023	BUY	$41.75 - $54.5 $13,234 - $17,276	317 Added 3.12%	10,488 $537,000
Q3 2022 Nov 09, 2022	SELL	$43.76 - $53.42 $1,837 - $2,243	-42 Reduced 0.41%	10,171 $445,000
Q2 2022 Aug 05, 2022	BUY	$46.53 - $55.17 $3,396 - $4,027	73 Added 0.72%	10,213 $535,000
Q1 2022 May 09, 2022	SELL	$45.75 - $56.69 $67,161 - $83,220	-1,468 Reduced 12.65%	10,140 $525,000
Q4 2021 Feb 08, 2022	BUY	$41.32 - $61.25 $32,890 - $48,755	796 Added 7.36%	11,608 $685,000
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $13,109 - $16,840	334 Added 3.19%	10,812 $465,000
Q4 2020 Feb 10, 2021	SELL	$33.47 - $42.56 $15,028 - $19,109	-449 Reduced 4.11%	10,478 $386,000
Q3 2020 Nov 03, 2020	BUY	$31.75 - $37.25 $31 - $37	1 Added 0.01%	10,927 $401,000
Q2 2020 Aug 06, 2020	BUY	$30.12 - $36.54 $30 - $36	1 Added 0.01%	10,926 $357,000
Q1 2020 May 08, 2020	BUY	$27.03 - $38.62 $4,973 - $7,106	184 Added 1.71%	10,925 $357,000
Q4 2019 Feb 03, 2020	BUY	$32.92 - $37.36 $44,145 - $50,099	1,341 Added 14.27%	10,741 $421,000
Q3 2019 Oct 23, 2019	SELL	$32.49 - $42.13 $47,987 - $62,226	-1,477 Reduced 13.58%	9,400 $338,000
Q2 2019 Jul 31, 2019	SELL	$36.98 - $41.52 $147,735 - $165,872	-3,995 Reduced 26.86%	10,877 $471,000
Q4 2018 Jan 29, 2019	BUY	$38.47 - $43.86 $38 - $43	1 Added 0.01%	14,872 $649,000
Q3 2018 Oct 24, 2018	BUY	$34.47 - $41.81 $123,092 - $149,303	3,571 Added 31.6%	14,871 $655,000
Q2 2018 Jul 20, 2018	BUY	$32.98 - $35.16 $32 - $35	1 Added 0.01%	11,300 $410,000
Q1 2018 Apr 23, 2018	BUY	$31.91 - $37.02 $31 - $37	1 Added 0.01%	11,299 $401,000
Q4 2017 Jan 16, 2018	BUY	$33.26 - $35.29 $33 - $35	1 Added 0.01%	11,298 $409,000
Q3 2017 Oct 25, 2017	BUY	$31.0 - $34.15 $350,207 - $385,792	11,297	11,297 $403,000

Others Institutions Holding PFE

# of Institutions

3,350

Shares Held

3.69B

Call Options Held

106M

Put Options Held

123M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $145B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisors, Ltd. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisors, Ltd. LLC with notifications on news.

Account

Capital Advisors, Ltd. LLC Pfizer Inc Transaction History